These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5298496)

  • 1. Alternative pathways of 5-hydroxindole metabolism. I. A comparison of D- and L-5-hydroxytryptophan metabolism in the rat.
    Arendt J; Contractor SF; Sandler M
    Biochem Pharmacol; 1967 Mar; 16(3):413-8. PubMed ID: 5298496
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative pathways of 5-hydroxyindole metabolism. II. The role transamination in the metabolism of D-5-hydroxytryptophan in the rat.
    Arendt J; Contractor SF; Sandler M
    Biochem Pharmacol; 1967 Mar; 16(3):419-22. PubMed ID: 5298497
    [No Abstract]   [Full Text] [Related]  

  • 3. Feedback control of rat brain 5-hydroxytryptamine synthesis.
    Macon JB; Sokoloff L; Glowinski J
    J Neurochem; 1971 Mar; 18(3):323-31. PubMed ID: 5314774
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporation of radioactivity from labeled serotonin and tryptamine into acid-insoluble material from subcellular fractions of brain. I. The nature of the substrate.
    Alivisatos SG; Ungar F
    Biochemistry; 1968 Jan; 7(1):285-92. PubMed ID: 5312358
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of monoamine oxidase inhibitors on 5-hydroxytryptamine synthesis in the brain.
    Weber LJ
    Proc Soc Exp Biol Med; 1966 Oct; 123(1):35-8. PubMed ID: 4380811
    [No Abstract]   [Full Text] [Related]  

  • 6. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake of 14C-labelled 5-hydroxytryptophan and 5-hydroxytryptamine by separated rat renal tubules.
    Inagaki C
    Jpn J Pharmacol; 1977 Feb; 27(1):79-86. PubMed ID: 301211
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution and metabolism of tryptamine in rat brain.
    Wu PH; Boulton AA
    Can J Biochem; 1973 Jul; 51(7):1104-12. PubMed ID: 4725358
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biosynthesis and metabolism of indolamines in the pineal organ of Lacerta (reptiles, larcertilians). II. Monoamine oxidase activity and incorporation of 3H-5-HTP and 3H-5-HT under normal and experimental conditions].
    Collin JP; Meiniel A
    Z Zellforsch Mikrosk Anat; 1973 Dec; 145(3):331-61. PubMed ID: 4543951
    [No Abstract]   [Full Text] [Related]  

  • 13. Depressed states and indolealkylamines.
    Coppen AJ
    Adv Pharmacol (1962); 1968; 6(Pt B):283-91. PubMed ID: 5301640
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the mechanism of inhibitory activity of pargyline on mitochondrial monoamine oxidases].
    Vina I; Gorkin VZ; Gridneva LI; Kliashtorin LB
    Biokhimiia; 1966; 31(2):282-90. PubMed ID: 5999925
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the administration of L-5-hydroxytryptophan and a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    J Neurochem; 1978 Sep; 31(3):613-20. PubMed ID: 308095
    [No Abstract]   [Full Text] [Related]  

  • 16. Replenishment by 5-hydroxytryptophan of the amine stores in the central 5-hydroxytryptamine neurons after depletion induced by reserpine or by an inhibitor of monoamine synthesis.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1967 Jul; 19(7):433-8. PubMed ID: 4382634
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Hydroxytryptophan (5-HTP) uptake and decarboxylation in the kitten brain.
    Kitahama K; Jouvet A; Fujimiya M; Nagatsu I; Arai R
    J Neural Transm (Vienna); 2002 May; 109(5-6):683-9. PubMed ID: 12111460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of 5-hydroxytryptamine in the methionine sulfoximine epileptogenic rat brain.
    Sellinger OZ; Dietz DD
    J Pharmacol Exp Ther; 1981 Jan; 216(1):77-82. PubMed ID: 6161244
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.